Blood tests could personalize TB dosing to boost success and cut harm
NCT ID NCT07607288
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study is tracking over 2,200 tuberculosis patients to see how the amount of TB drugs in their blood relates to how well the treatment works and whether they have side effects. By measuring drug levels, researchers hope to find ways to adjust doses for each person, especially those with other health issues or hard-to-treat TB. The goal is to make treatment safer and more effective, but this is an observational study, not a test of a new medicine.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- antituberculosis drugs (rifampicin, isoniazid, ethambutol, pyrazinamide)
- What this could lead to
- If successful, this could help doctors adjust TB drug doses for each patient, improving treatment effectiveness and reducing side effects like liver or heart damage.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test a new drug or cure. Results may not apply to all TB patients, and individual dose adjustments still need further validation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THERAPEUTIC DRUG MONITORING (TDM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing chest hospital affiliated to Capital medical university, Beijing Tuberculosis & Thoracic Tumor Research Institute
Beijing, Beijing Municipality, 101149, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune profiling unlock the hidden stages of tuberculosis?
- Could inhaled TB drugs curb the spread of Drug-Resistant tuberculosis?
- Can new tests predict who will develop active TB?
- Could a 3-Month TB cocktail replace the standard 6-Month regimen?
- Could a simple blood test ensure the right TB dose for kids?
- Community-Driven TB screening aims to reach vulnerable immigrants